W W A van den Broek, M E Gimbel, R S Hermanides, C Runnett, R F Storey, P Knaapen, M E Emans, R M Oemrawsingh, J Cooke, G Galasko, R Walhout, M G Stoel, C von Birgelen, Paul F M M van Bergen, S L Brinckman, I Aksoy, A Liem, A W J Van't Hof, J W Jukema, A A C M Heestermans, D Nicastia, H Alber, D Austin, A Nasser, V Deneer, J M Ten Berg
BACKGROUND: As life expectancy increases, the population of older individuals with coronary artery disease and frailty is growing. We aimed to assess the impact of patient-reported frailty on the treatment and prognosis of elderly early survivors of non-ST-elevation acute coronary syndrome (NSTE-ACS). METHODS: Frailty data were obtained from two prospective trials, POPular Age and the POPular Age Registry, which both assessed elderly NSTE-ACS patients. Frailty was assessed one month after admission with the Groningen Frailty Indicator (GFI) and was defined as a GFI-score of 4 or higher...
March 7, 2024: International Journal of Cardiology